Verification of nanopore sequencing technology for clinical carbapenem-resistant Enterobacterales surveillance
Ela Sauerborn, Ebenezer Foster-Nyarko, Katrin Schröder, Annika Sobkowiak, Samir V. F. Atum, Friedemann E. Gebhardt, Nina Wantia, Lara Urban
This study verifies nanopore sequencing for CRE surveillance by comparing it to routine diagnostics and determining required sequencing depths for various clinical tasks.
bioRxiv · Aug 10, 2026 · PreprintGenomics